Presently, over 30 players are engaged in the development of digital solutions for different types
Advances in information technology andbiomedical science have enabled the development of digital solutions forbiomarkers, which, owing to the myriad of pertinent applications, are beingincreasingly adopted in modern healthcare practices.
To order this 270+ page report, which features135+ figures and 140+ tables, please visit https://www.rootsanalysis.com/reports/digital-biomarkers-market.html
The USD 8.86 billion (by 2030) financialopportunity within the digital therapeutics market has been analyzed across thefollowing segments:
§ Typeof Solution
§ Standalone SoftwareApplication
§ Software Application+ Device + Personal Coach
§ Software Application+ Device + AI Support
§ Software Application+ Device
§ Software Application+ AI Support
§ Software Application+ Personal Coach
§ Other Types ofSolutions
§ Purposeof Solution
§ MedicationReplacement
§ MedicationAugmentation
§ Typeof Therapy
§ Curative
§ Preventive
§ BusinessModel
§ Businessto Consumer (Patients and Caregivers)
§ Businessto Business (Healthcare Providers, Payers, Employers andPharmaceutical Companies)
§ TherapeuticAreas
§ CardiovascularDisorders
§ ChronicPain
§ MentalHealth Problems
§ MetabolicDisorders
§ NeurologicalDisorders
§ RespiratoryDisorders
§ SleepDisorders
§ SubstanceUse Disorders
§ Others
§ KeyGeographical Regions
§ NorthAmerica
§ Europe
§ Asia-Pacific
§ Restof the world
The Digital Solutions forBiomarkers Market, 2021-2030, report features the following companies,which we identified to be key players in this domain:
§ Akili Interactive
§ AiCure
§ Cogito Corp
§ JanssenPharmaceuticals
§ Huma
§ Mindstrong Health
§ Oura
§ Pear Therapeutics
§ Roche
§ Sonde Health
§ Vocalis Health
§ Winterlight Labs
Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. Market Landscape
5. Key Market Insights
6. Company Profiles
7. Product Competitiveness Analysis
9. Global Events Analysis
8. Funding and Investment Analysis
9. Partnerships and Collaborations
10. Go-To-Market Strategy
11. Big Pharma Initiatives
12. Market Forecast
13. Impact of COVID-19 Pandemic on Digital Solutionsfor Biomarkers Market
14. Conclusion
15. Appendix 1: Tabulated Data
16. Appendix 2: List of Companies and Organizations
To purchase a copy, please visit https://www.rootsanalysis.com/reports/digital-biomarkers-market.html
Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
gaurav.chaudhary@rootsanalysis.com
